U-M Team Makes Strides in Tissue Regeneration Research

Groundbreaking new research marrying high-intensity focused ultrasound with genetically modified cells may spur bone and soft tissue regeneration.

7:00 AM

Author | Jina Sawani

Growth factors, or substances like hormones or vitamins that are required for the stimulation of growth within living cells, play a critical role in tissue regeneration.

Without them, many cellular responses fail to be triggered, hindering tissue repair and development, says Mario Fabiilli, Ph.D., a research assistant professor of radiology at the University of Michigan.

LISTEN UP: Add the new Michigan Medicine News Break to your Alexa-enabled device, or subscribe to our daily audio updates on iTunes, Google Play and Stitcher.

"Because growth factors are produced in precisely controlled ways, however, many researchers run into the challenge of developing effective methods for reproducing their patterns in real time," he says.

This inspired Fabiilli and Renny Franceschi, Ph.D., a professor of periodontics and oral medicine at U-M, to co-lead a team that explored a potential therapy for bone and soft tissue regeneration. Their groundbreaking research was recently published in the journal Biomaterials.

SEE ALSO: Boosting a Key Protein to Help Bones That Won't Heal

The team, consisting of researchers from a broad range of fields including biomedical engineering and dentistry, found that using high-intensity focused ultrasound, or HIFU, a method approved by the Food and Drug Administration for treating various diseases, can spur tissue regeneration when coupled with genetically modified cells that contain a "gene switch."

By design, the gene switch controls expression of a molecule, similar to a growth factor. However, Fabiilli and his team's gene switch was novel because it required both heat shock and a ligand for activation: "When we heated the cells just 5 to 8 degrees Celsius above body temperature in the presence of a specific activating ligand, the gene switch is turned on, thus stimulating gene expression. It was really interesting to observe," Fabiilli says.

The ingenious road to discovery

First, the team developed a scaffold that was both biocompatible — or not harmful to living tissue — and easily heated when exposed to HIFU.

For tissue regeneration, delivered cells are commonly encapsulated within a scaffold, which is implanted at the site of the defective tissue. The scaffold, which mimics the extracellular matrix, provides a 3D microenvironment that supports cellular processes involved in tissue regrowth.

"Hydrogels, which are composed of hydrophilic polymers, are a commonly used class of scaffolds," Fabiilli says. "Due to their high water content, the acoustic attenuation of hydrogels is very low. This means that conventional hydrogels do not heat very efficiently."

To offset this problem, the researchers needed to develop a composite scaffold with an acoustic attenuation similar to soft tissue.

MORE FROM MICHIGAN: Sign up for our weekly newsletter

With this in mind, they developed a composite hydrogel scaffold consisting of fibrin and hydroxyapatite particles. Fibrin, a major component of blood clots, is commonly used for the delivery of cells in tissue regeneration. Hydroxyapatite is the mineral component of bone.

The team then encapsulated cells containing the gene switch, which controlled activation of a firefly luciferase (fLuc) transgene, within the composite scaffolds and the fibrin-only scaffolds. Both versions were simultaneously exposed to varying intensities of HIFU and the activating ligand, which was rapamycin.

SEE ALSO: Stem Cells Provide Greater Insight into Rotator Cuff Disease

Because of the higher attenuation, the composite scaffolds heated more efficiently, which yielded transgene expression. The fibrin-only scaffolds did not demonstrate the same features.

Additionally, the team used bioluminescence imaging to show that fLuc activation could be spatially patterned by moving the focus of the HIFU across the cell-loaded composite scaffolds.

"We were able to maintain that gene expression was controlled within cubic millimeter precision," Fabiilli says.

Further investigation

Fabiilli and his team also showed that gene activation could be controlled in vivo, or within a living organism.

"We incorporated the cells containing the gene switch-controlling expression fLuc into composite scaffolds and then subcutaneously implanted them into mice," Fabiilli says. "And interestingly enough, we observed significantly higher rates of expression (using bioluminescence imaging) in the constructs that were exposed to both HIFU and ligand, versus ligand alone."

Eventually, the team also found that the gene switch could be turned on multiple times, which could be beneficial in promoting tissue regeneration.

"We went back and applied both the HIFU and ligand and observed repeated activation of transgene expression eight days after the initial round," Fabiilli says. "This was absolutely fascinating and gives way to so many more possibilities when it comes to tissue regrowth."

More Articles About: Health Tech Basic Science and Laboratory Research Genetic Testing Ultrasound Gene Therapy All Research Topics
Health Lab word mark overlaying blue cells
Health Lab

Explore a variety of healthcare news & stories by visiting the Health Lab home page for more articles.

Media Contact Public Relations

Department of Communication at Michigan Medicine

[email protected]


Stay Informed

Want top health & research news weekly? Sign up for Health Lab’s newsletters today!

Featured News & Stories Jianping Fu, Ph.D., Professor of Mechanical Engineering at the University of Michigan and the corresponding author of the paper being published at Nature discusses his team’s work in their lab with Jeyoon Bok, Ph.D. candidate at the Department of Mechanical Engineering.
Health Lab
Human stem cells coaxed to mimic the very early central nervous system
The first organized stem cell culture model that resembles all three sections of the embryonic brain and spinal cord could shed light on developmental brain diseases
Graphic showing pills, a heart and brain with data on aspirin use
Health Lab
Aspirin can prevent a second heart attack or stroke, but many don’t use it
Washington University School of Medicine and Michigan Medicine researchers found that fewer than half of people who have experienced a heart attack or stroke use aspirin to prevent a second one.
Illustration of a microscope
Health Lab
Hippo signaling pathway gives new insight into systemic sclerosis
Study focuses on Hippo signaling pathway as critical link between fibrosis, vascular dysfunction, and sex bias in systemic sclerosis
Headshot of Anne Draelos
Research News
U-M's Anne Draelos named a 2024 Sloan Research Fellow in neuroscience
Anne Draelos, Ph.D., Assistant Professor of Biomedical Engineering and Computational Medicine & Bioinformatics, has been named a 2024 Sloan Research Fellow in Neuroscience.
Illustration of a doctor and patient looking at ultrasound
Health Lab
Novel device detects cervix “ripening” to predict normal and abnormal labor
Multi-specialty team is studying a non-invasive method to measure underlying cervical tissue changes that precede birth with the hopes of predicting timing of birth.
vial of blood in container lab blue yellow grainy graphic
Health Lab
Unveiling potential diagnostic, treatment target for APS-related thrombocytopenia
Researchers at the University of Michigan Health have unveiled a new mechanism that drives thrombocytopenia and a potential clinically actionable biomarker for antiphospholipid syndrome associated thrombocytopenia.